封面
市场调查报告书
商品编码
2019916

2026-2034年全球神经外科医疗设备市场规模、份额、趋势和成长分析报告

Global Neurosurgery Devices Market Size, Share, Trends & Growth Analysis Report 2026-2034

出版日期: | 出版商: Value Market Research | 英文 139 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

预计神经外科医疗设备市场规模将从 2025 年的 193.6 亿美元成长到 2034 年的 526.5 亿美元,2026 年至 2034 年的复合年增长率为 11.76%。

由于神经系统疾病和脑部相关疾病的发生率不断上升,全球神经外科医疗设备市场正经历强劲成长。神经外科手术中使用的医疗设备,包括手术器械、导航系统和植入,对于治疗脑肿瘤、脊髓疾病和创伤性损伤等疾病至关重要。医疗技术的进步显着提高了手术精确度和患者预后。

推动神经成长要素包括老年人口的增加(老年人易患神经系统疾病)以及微创手术技术的普及。机器人辅助手术和先进影像系统等技术创新进一步提高了神经外科手术的有效性。此外,不断上涨的医疗成本也促进了先进医疗设备的应用。

未来,随着持续创新和新一代外科技术的研发,市场预计将持续扩张。在新兴国家,随着医疗基础设施的改善,成长机会也将随之而来。随着神经科学研究的进展,新的治疗方法和医疗设备将进一步推动市场成长,并改善患者照护效果。

目录

第一章:引言

第二章执行摘要

第三章 市场变数、趋势与框架

  • 市场谱系展望
  • 渗透率和成长前景分析
  • 价值链分析
  • 法律规范
    • 标准与合规性
    • 监管影响分析
  • 市场动态
    • 市场驱动因素
    • 市场限制因素
    • 市场机会
    • 市场挑战
  • 波特五力分析
  • PESTLE分析

第四章 全球神经外科医疗设备市场:依产品划分

  • 市场分析、洞察与预测
  • 神经刺激装置
  • 介入神经放射学设备
  • 神经外科导航系统
  • 脑脊髓液(CSF)管理装置
  • 其他的

第五章 全球神经外科医疗设备市场:依应用领域划分

  • 市场分析、洞察与预测
  • 脊髓刺激疗法
  • 深部脑部刺激
  • 神经科学用内视镜

第六章 全球神经外科医疗设备市场:依最终用户划分

  • 市场分析、洞察与预测
  • 医院
  • 门诊手术中心
  • 其他的

第七章 全球神经外科医疗设备市场:依地区划分

  • 区域分析
  • 北美市场分析、洞察与预测
    • 我们
    • 加拿大
    • 墨西哥
  • 欧洲市场分析、洞察与预测
    • 英国
    • 法国
    • 德国
    • 义大利
    • 俄罗斯
    • 其他欧洲国家
  • 亚太市场分析、洞察与预测
    • 印度
    • 日本
    • 韩国
    • 澳洲
    • 东南亚
    • 其他亚太国家
  • 拉丁美洲市场分析、洞察与预测
    • 巴西
    • 阿根廷
    • 秘鲁
    • 智利
    • 其他拉丁美洲国家
  • 中东和非洲市场分析、洞察与预测
    • 沙乌地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中东和非洲国家

第八章 竞争情势

  • 最新趋势
  • 公司分类
  • 供应链和销售管道合作伙伴(根据现有资讯)
  • 市场占有率和市场定位分析(基于现有资讯)
  • 供应商情况(基于现有资讯)
  • 策略规划

第九章:公司简介

  • 主要公司的市占率分析
  • 公司简介
    • Medtronic Plc
    • Johnson & Johnson
    • Stryker Corporation
    • Abbott Laboratories
    • B. Braun Melsungen AG
    • Ackermann Instrumente GmbH
    • Integra LifeSciences Corporation
    • Boston Scientific Corporation
    • BIOTRONIK SE & Co. KG
    • Adeor Medical AG
简介目录
Product Code: VMR11218387

The Neurosurgery Devices Market size is expected to reach USD 52.65 Billion in 2034 from USD 19.36 Billion (2025) growing at a CAGR of 11.76% during 2026-2034.

The global neurosurgery devices market is experiencing robust growth due to the increasing prevalence of neurological disorders and brain-related conditions. Devices used in neurosurgery, such as surgical instruments, navigation systems, and implants, are essential for treating conditions like brain tumors, spinal disorders, and traumatic injuries. Advancements in medical technology have significantly improved surgical precision and patient outcomes.

Key drivers include the growing aging population, which is more susceptible to neurological disorders, and the increasing adoption of minimally invasive surgical techniques. Technological innovations such as robotic-assisted surgeries and advanced imaging systems have further enhanced the effectiveness of neurosurgical procedures. Additionally, rising healthcare expenditure has supported the adoption of advanced medical devices.

In the future, the market is expected to expand with continuous innovation and the development of next-generation surgical technologies. Emerging economies will offer growth opportunities due to improving healthcare infrastructure. As research in neuroscience advances, new treatment approaches and devices will further drive market growth and improve patient care outcomes.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product

  • Neurostimulation Devices
  • Neurointerventional Devices
  • Neurosurgical Navigation Systems
  • Cerebral Spinal Fluid (CSF) Management Devices
  • Others

By Application

  • Spinal Cord Stimulation
  • Deep Brain Stimulation
  • Neuroendoscopy

By End User

  • Hospitals
  • Ambulatory Surgical Centers
  • Others

COMPANIES PROFILED

  • Medtronic plc, Johnson Johnson, Stryker Corporation, Abbott Laboratories, B Braun Melsungen AG, Ackermann Instrumente GmbH, Integra LifeSciences Corporation, Boston Scientific Corporation, BIOTRONIK SE Co KG, Adeor Medical AG
  • We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL NEUROSURGERY DEVICES MARKET: BY PRODUCT 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Product
  • 4.2. Neurostimulation Devices Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Neurointerventional Devices Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.4. Neurosurgical Navigation Systems Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.5. Cerebral Spinal Fluid (CSF) Management Devices Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.6. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL NEUROSURGERY DEVICES MARKET: BY APPLICATION 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast Application
  • 5.2. Spinal Cord Stimulation Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Deep Brain Stimulation Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.4. Neuroendoscopy Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL NEUROSURGERY DEVICES MARKET: BY END USER 2022-2034 (USD MN)

  • 6.1. Market Analysis, Insights and Forecast End User
  • 6.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.3. Ambulatory Surgical Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL NEUROSURGERY DEVICES MARKET: BY REGION 2022-2034 (USD MN)

  • 7.1. Regional Outlook
  • 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.2.1 By Product
    • 7.2.2 By Application
    • 7.2.3 By End User
    • 7.2.4 United States
    • 7.2.5 Canada
    • 7.2.6 Mexico
  • 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.3.1 By Product
    • 7.3.2 By Application
    • 7.3.3 By End User
    • 7.3.4 United Kingdom
    • 7.3.5 France
    • 7.3.6 Germany
    • 7.3.7 Italy
    • 7.3.8 Russia
    • 7.3.9 Rest Of Europe
  • 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.4.1 By Product
    • 7.4.2 By Application
    • 7.4.3 By End User
    • 7.4.4 India
    • 7.4.5 Japan
    • 7.4.6 South Korea
    • 7.4.7 Australia
    • 7.4.8 South East Asia
    • 7.4.9 Rest Of Asia Pacific
  • 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.5.1 By Product
    • 7.5.2 By Application
    • 7.5.3 By End User
    • 7.5.4 Brazil
    • 7.5.5 Argentina
    • 7.5.6 Peru
    • 7.5.7 Chile
    • 7.5.8 Rest of Latin America
  • 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.6.1 By Product
    • 7.6.2 By Application
    • 7.6.3 By End User
    • 7.6.4 Saudi Arabia
    • 7.6.5 UAE
    • 7.6.6 Israel
    • 7.6.7 South Africa
    • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

  • 8.1. Recent Developments
  • 8.2. Company Categorization
  • 8.3. Supply Chain & Channel Partners (based on availability)
  • 8.4. Market Share & Positioning Analysis (based on availability)
  • 8.5. Vendor Landscape (based on availability)
  • 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL NEUROSURGERY DEVICES INDUSTRY

  • 9.1. Top Companies Market Share Analysis
  • 9.2. Company Profiles
    • 9.2.1 Medtronic Plc
    • 9.2.2 Johnson & Johnson
    • 9.2.3 Stryker Corporation
    • 9.2.4 Abbott Laboratories
    • 9.2.5 B. Braun Melsungen AG
    • 9.2.6 Ackermann Instrumente GmbH
    • 9.2.7 Integra LifeSciences Corporation
    • 9.2.8 Boston Scientific Corporation
    • 9.2.9 BIOTRONIK SE & Co. KG
    • 9.2.10 Adeor Medical AG